UCB plans new biologics pilot plant in Braine-l'Alleud, Belgium

UCB plans to build a cGMP Biologics Pilot Facility on its site of Braine-l'Alleud in Belgium, further executing its strategy to become the next generation biopharma leader focusing on central nervous system (CNS) and immunology.

The cGMP Biologics Pilot Facility is expected to become operational early 2012. Advanced feasibility studies are currently ongoing.

The cGMP Biologics Pilot Facility will allow UCB to further optimize the bio-manufacturing processes for its biological compounds under development, extending its knowledge and competencies in this field.

In the context of this project, UCB welcome companies having an interest in being invited to potential future tenders to register themselves by filling in the form available through the following link.

UCB will assess applications, to its sole satisfaction on a combination of criteria such as, but not limited to:

• experience in similar projects;
• project capability;
• ability to maintain control over project costs and schedule;
• the added value you can bring to the project;
• demonstrable ability to understand and meet UCB requirements.

Please refrain from making inquiries about the evaluation of your application as no answer will be given to such inquiries.

Please note that this does not constitute any commitment from UCB but gives companies, once their registration is validated and approved, the opportunity to become part of the list of potential UCB suppliers who may be invited for future tenders.

We thank you in advance for your interest in our project.